Product Program year 2020 Source: CMS Open Payments

Olympus ENT Fiber Scopes

Device ENT Products

Open in the dashboard

General payments

$142,208

240 payments

Research payments

$0

0 payments

Through program year 2020, $142,208 in general payments and $0 in research payments were reported against Olympus ENT Fiber Scopes (ENT Products).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $14,472 41
2019 General $127,737 199

Breakdown

Who paid General payments · program years 2019–2020
  1. Olympus America Inc. $141,146 239 payments
  2. Olympus Corporation $1,063 1 payment
Top recipients General payments · program year 2020
  1. Aaron Friedman Otolaryngology · Cincinnati, OH $5,155 36% · 4 payments
  2. Cleveland Clinic Hospital Teaching hospital · OH $2,600 18% · 1 payment
  3. Uci Medical Center Teaching hospital · CA $2,500 17% · 1 payment
  4. Peter Belafsky Otolaryngology · Sacramento, CA $1,530 11% · 2 payments
  5. Satish Govindaraj Otolaryngology · New York, NY $1,063 7% · 1 payment

The top 5 of 36 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Otolaryngology $8,873 95% · 21 practitioners
  2. Otology & Neurotology Otolaryngology $208 2% · 2 practitioners
  3. Facial Plastic Surgery Otolaryngology $115 1% · 1 practitioner
  4. Radiation Oncology Radiology $102 1% · 5 practitioners
  5. Pediatric Otolaryngology Otolaryngology $51 <1% · 3 practitioners

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Ohio $7,755 54% · 2 recipients
  2. California $4,179 29% · 12 recipients
  3. New York $1,063 7% · 1 recipient
  4. Colorado $582 4% · 6 recipients
  5. Louisiana $542 4% · 5 recipients

The top 5 of 8 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

240 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record